The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B reactivation (HBVr) in at-risk individuals, recommending antiviral prophylaxis for ...
AGA guidance strongly recommends antiviral prophylaxis for patients at high risk for hepatitis B reactivation. At-risk patients not recommended for antiviral prophylaxis should be actively monitored.
New recommendations address advances in immunosuppressive therapies and highlight antiviral prophylaxis for high ... the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback